You are invited to the next webinar: Thursday ... - CLL Support

CLL Support

23,253 members39,949 posts

You are invited to the next webinar: Thursday 20 May at 2.00pm London (10.00 am EST) Title: ‘Autoimmune complications of CLL'

pkguk2 profile image
pkguk2PartnerCLL Support Association
2 Replies

Speaker: Dr. Helen Marr, Consultant Haematologist at the Freeman Hospital, Newcastle on Tyne.

We know that CLL and SLL patients have compromised immune systems. However, a complication can arise when antibodies or lymphocytes are produced against substances naturally present in the body. Dr. Marr will be examining this topic which is of great relevance for all CLL and SLL patients.

We will start at 2:00 pm, and you can join from 1:45. The Webinar will close by 3:30 pm, allowing plenty of time for questions

Please register by emailing: webinar@cllsupport.org.uk

We look forward to welcoming you!

Written by
pkguk2 profile image
pkguk2
Partner
To view profiles and participate in discussions please or .
2 Replies
Accordion profile image
Accordion

Great! Thank you!

bennevisplace profile image
bennevisplace

Thank you, a subject well worth learning more of.

Lovely bluebell wood!

Not what you're looking for?

You may also like...

UK Zoom meeting - COVID-19 and shielding update for UK CLL Patients

ZOOM invite details below May 7, 2020, 10:00 AM - Webinar - COVID-19 and shielding update for CLL...
Jm954 profile image
Administrator

Is It Time to Treat Your CLL? What You Need to Know

Topic: Is It Time to Treat Your CLL? What You Need to Know Description: When it’s time to move...
lankisterguy profile image
Volunteer

Dr. Neil Kay: CLL Society Webinar, Just Diagnosed: What Do I Need to Know?

HI, Please join us for a CLL Society Webinar, Just Diagnosed: What Do I Need to Know? on Tuesday,...
bkoffman profile image
CLL CURE Hero

Survey for CLL patients having taken Venetoclax or Acalabrutinib

CLL/SLL Patient Survey If you have CLL or SLL and have been treated with the following therapies,...

Please share experience of venetoclax plus obinutuzimab or acalabrutinib mono treatment in an important survey

Reminder - please complete the survey if you are any of the above treatments. At the moment we...
Jm954 profile image
Administrator